n-phenylphthalimide has been researched along with 2,6-dimethylphenylphthalimide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, A; Hashimoto, Y; Kato, F; Kato, M; Kobayashi, Y; Miyachi, H; Ogasawara, A; Uchimura, E; Watanabe, N | 1 |
| Hashimoto, Y; Nagasawa, K; Noguchi, T; Shimazawa, R | 1 |
| Hashimoto, Y; Iguchi, T; Inatsuki, S; Kizaki, M; Kobayashi, H; Miyachi, H; Noguchi, T; Oda, S | 1 |
| Fujimoto, H; Hashimoto, Y; Miyachi, H; Miyajima, A; Noguchi, T; Sano, H | 1 |
4 other study(ies) available for n-phenylphthalimide and 2,6-dimethylphenylphthalimide
| Article | Year |
|---|---|
Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity.
Topics: Cell Survival; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunologic Factors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Okadaic Acid; Optical Rotation; Phthalimides; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1997 |
Thalidomide and its analogues as cyclooxygenase inhibitors.
Topics: Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Substrate Specificity; Thalidomide | 2002 |
Tubulin-polymerization inhibitors derived from thalidomide.
Topics: Colchicine; Indoles; Isoindoles; Lactones; Macrolides; Nerve Tissue Proteins; Thalidomide; Time Factors; Tubulin; Tubulin Modulators | 2005 |
Angiogenesis inhibitors derived from thalidomide.
Topics: Angiogenesis Inhibitors; Endothelium, Vascular; Humans; Structure-Activity Relationship; Thalidomide; Umbilical Veins | 2005 |